Skip to content
DataLookout
Menu

NCT07906652

Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With Atorvastatin in the Treatment of Atypical Pneumonia

StatusEnrolling by Invitation
PhaseEarly Phase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Percentage of Participants With an Increase of at Least 1 Point in Cerebral Perfusion Staging Score
Timeframe: Baseline (before intervention) and the day after completion of the 3-month treatment course

Secondary (7)

Fugl-Meyer Assessment of Motor Function Score
Modified Barthel Index Score
Montreal Cognitive Assessment Score
National Institutes of Health Stroke Scale Score
Incidence of New Intracerebral Hemorrhage
Show 2 moreShow less
Incidence of Recurrent or New Cerebral Infarction
All-Cause Mortality

Arms and interventions

Atorvastatin + Replenishing Five Herbs DecoctionExperimental

Treatment with "Replenishing Five Herbs Decoction" (200ml per dose, twice daily, one dose per application, as per internal protocol of Nanjing Central Hospital), supplemented with Atorvastatin (produced by Pfizer, USA, national drug registration number H20051407, 10mg, one tablet daily).

Atorvastatin + Replenishing Five Herbs Decoction PlaceboPlacebo comparator

The treatment consists of a placebo pill, combined with atorvastatin (produced by Pfizer, registration number H20051407, 10mg, taken once daily, one tablet). The placebo is a mixture of 10% herbal extract and rice, combined with edible seasonings, and has the same appearance, shape, smell, and specifications as the "Yang Huo Han Wu" formula.

Drugs: Atorvastatin, Replenishing Five Herbs Decoction, Replenishing Five Herbs Decoction Placebo

Sites

1 site in 1 country

  • Jiangsu Province Hospital (Jiangsu Provincial People's Hospital)Nanjing, Jiangsu, China